enVVeno Medical Corp
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Irvine, CA
NVNO chart
What traders are saying about $NVNO
Latest postsenVVeno Medical Corp news
- A fund's 17,142 shares form part of an amended enVVeno Medical (NVNO) passive stake report.
Stock Titan ·
- enVVeno Medical Corporation (NVNO) Seasonal returns chart
Yahoo Finance UK ·
- enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
Yahoo Finance ·
- enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study
Yahoo Finance ·
- enVVeno Medical Releases New Episode of "WTF" Video Series Featuring CEO Rob Berman
Yahoo Finance ·
- enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial
Yahoo Finance ·
- enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
Yahoo Finance ·
- enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand
Yahoo Finance ·
- enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
Yahoo Finance ·
- Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments
Yahoo Finance ·
- enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
Yahoo Finance ·
- enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
Yahoo Finance ·
enVVeno Medical Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$19.5M | -$21.8M | -$23.5M | -$24.7M |
| Diluted EPS | $-33.06 | $-44.53 | $-1.91 | $-2.20 |
| Total assets (year end) | $29.6M | $45.0M | $48.6M | $41.7M |
| Cash and equivalents (year end) | $3.1M | $1.8M | $3.6M | $4.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About enVVeno Medical Corp
- Ticker
- NVNO (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Irvine, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1661053
- Former names
- Hancock Jaffe Laboratories, Inc.
Frequently asked questions
What exchange is enVVeno Medical Corp listed on?
enVVeno Medical Corp trades on the Nasdaq under the ticker symbol NVNO.
What industry is enVVeno Medical Corp in?
enVVeno Medical Corp is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is enVVeno Medical Corp headquartered?
enVVeno Medical Corp's business address on file with the SEC is in Irvine, CA.
When does enVVeno Medical Corp's fiscal year end?
enVVeno Medical Corp's fiscal year ends on December 31.
How much revenue did enVVeno Medical Corp report?
enVVeno Medical Corp reported $31,243 in revenue for calendar year 2019, according to its SEC filings.